Suyash Shringarpure

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• LLM-Assisted Reanalysis of Unsolved Rare Disease Genomes Increases Diagnostic Yield

  NEJM AI · 2026-06-18 · 1 citations

• Genetic predictors of GLP1 receptor agonist weight loss and side effects

  Nature · 2026-04-08 · 10 citations

• Genetic co-regulation of neopterin and Parkinson’s disease

  npj Parkinson s Disease · 2026-02-10

• Step change in glaucoma polygenic risk score performance enables clinical utility and disease prediction across all major ancestries

  medRxiv · 2026-01-24

• Integrating Polygenic Risk Improves Generative Forecasting of Disease Trajectories

  2025-12-01

• Large language models identify causal genes in complex trait GWAS

  2025-12-01

• Genome-wide association study of delay discounting identifies 11 loci and reveals transdiagnostic associations across mental and physical health

  Molecular Psychiatry · 2025-11-25 · 2 citations

• Large language models identify causal genes in complex trait GWAS

  2025-11-16

• PRSformer: Disease Prediction from Million-Scale Individual GenotypesPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-10-27 · 1 citations

• Dyslexia Polygenic Index and Socio-Economic Status Interaction Effects on Reading Skills in Australia and the United Kingdom

  Behavior Genetics · 2025-09-01

• Association between polygenic risk and survival in breast cancer patients

  BMC Cancer · 2025-08-28 · 2 citations

• Multivariate genome-wide association analysis of dyslexia and quantitative reading skill improves gene discovery

  Translational Psychiatry · 2025-08-18 · 1 citations

• Large-scale genome-wide analyses of stuttering

  Nature Genetics · 2025-07-28 · 8 citations

• Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores

  npj Parkinson s Disease · 2025-07-03 · 5 citations

• Figure 3 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15

• Figure S1 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15

• Table 2 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15

• Figure S3 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15

• Supplementary Data from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15

• Figure S2 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid MalignanciesPreprint

  2025-01-15